Literature DB >> 23810413

Human complement control and complement evasion by pathogenic microbes--tipping the balance.

Peter F Zipfel1, Teresia Hallström, Kristian Riesbeck.   

Abstract

Complement is a central homeotic system of mammals and represents the first defense line of innate immunity. The human complement system is aimed to maintain homeostasis by recognizing and removing damaged or modified self material, as well as infectious foreign microbes. However, pathogenic microbes also control and escape the host complement and immune attack. The increasing resistance of microbial pathogens to either antibiotics or antifungal drugs is a major health problem and is of global interest. Therefore the topic how pathogenic microbes escape human complement and immune control is of high and of central interest. Identifying and defining the action of proteins involved in this intense immune interaction and understanding how these proteins interact is of relevance to design new control strategies. In this review we summarize the complement system of the human host and how this cascade drives effector functions. In addition, we summarize how diverse pathogenic microbes control, modulate and block the complement response of their host. The characterization of pathogen derived virulence factors and complement escape proteins reveals patterns of multiplicity, diversity and redundancy among pathogen encoded proteins. Sequence variability of immune and also complement escape proteins is largely driven by antigenic diversity and adaptive immunity. However common complement escape principles are, emerging in terms of conserved binding repertoire for host regulators and evasion among the large variety of infectious microbes. These conserved and common escape features are relevant and they provide challenging options for new therapeutic approaches.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Complement escape; Immune control; Immune escape; Infection; Pathogenic Microbes

Mesh:

Substances:

Year:  2013        PMID: 23810413     DOI: 10.1016/j.molimm.2013.05.222

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  49 in total

1.  Human IgG Increases Virulence of Streptococcus pyogenes through Complement Evasion.

Authors:  David Ermert; Antonin Weckel; Michal Magda; Matthias Mörgelin; Jutamas Shaughnessy; Peter A Rice; Lars Björck; Sanjay Ram; Anna M Blom
Journal:  J Immunol       Date:  2018-04-06       Impact factor: 5.422

2.  Identification of the pharmacophore of the CC chemokine-binding proteins Evasin-1 and -4 using phage display.

Authors:  Pauline Bonvin; Steven M Dunn; François Rousseau; Douglas P Dyer; Jeffrey Shaw; Christine A Power; Tracy M Handel; Amanda E I Proudfoot
Journal:  J Biol Chem       Date:  2014-09-29       Impact factor: 5.157

3.  Retargeting pre-existing human antibodies to a bacterial pathogen with an alpha-Gal conjugated aptamer.

Authors:  Sascha A Kristian; John H Hwang; Bradley Hall; Emma Leire; John Iacomini; Robert Old; Uri Galili; Charles Roberts; Kary B Mullis; Mike Westby; Victor Nizet
Journal:  J Mol Med (Berl)       Date:  2015-05-05       Impact factor: 4.599

Review 4.  Complement and Bacterial Infections: From Molecular Mechanisms to Therapeutic Applications.

Authors:  Dani A C Heesterbeek; Mathieu L Angelier; Richard A Harrison; Suzan H M Rooijakkers
Journal:  J Innate Immun       Date:  2018-08-27       Impact factor: 7.349

5.  Streptococcus pneumoniae phosphoglycerate kinase is a novel complement inhibitor affecting the membrane attack complex formation.

Authors:  Anna M Blom; Simone Bergmann; Marcus Fulde; Kristian Riesbeck; Vaibhav Agarwal
Journal:  J Biol Chem       Date:  2014-10-03       Impact factor: 5.157

6.  Identification of peptidic inhibitors of the alternative complement pathway based on Staphylococcus aureus SCIN proteins.

Authors:  Brady J Summers; Brandon L Garcia; Jordan L Woehl; Kasra X Ramyar; Xiaolan Yao; Brian V Geisbrecht
Journal:  Mol Immunol       Date:  2015-06-04       Impact factor: 4.407

7.  Pathogenic Leptospira species acquire factor H and vitronectin via the surface protein LcpA.

Authors:  Ludmila Bezerra da Silva; Lidia Dos Santos Miragaia; Leandro Carvalho Dantas Breda; Cecilia Mari Abe; Mariana Costa Braga Schmidt; Ana Maria Moro; Denize Monaris; Jonas Nascimento Conde; Mihály Józsi; Lourdes Isaac; Patrícia Antônia Estima Abreu; Angela Silva Barbosa
Journal:  Infect Immun       Date:  2014-12-22       Impact factor: 3.441

8.  CovR Regulates Streptococcus mutans Susceptibility To Complement Immunity and Survival in Blood.

Authors:  Lívia A Alves; Ryota Nomura; Flávia S Mariano; Erika N Harth-Chu; Rafael N Stipp; Kazuhiko Nakano; Renata O Mattos-Graner
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

9.  New insights into disease-specific absence of complement factor H related protein C in mouse models of spontaneous autoimmune diseases.

Authors:  Gaurav Mehta; Viviana P Ferreira; Christine Skerka; Peter F Zipfel; Nirmal K Banda
Journal:  Mol Immunol       Date:  2014-07-15       Impact factor: 4.407

10.  Binding of Streptococcus pneumoniae endopeptidase O (PepO) to complement component C1q modulates the complement attack and promotes host cell adherence.

Authors:  Vaibhav Agarwal; Magdalena Sroka; Marcus Fulde; Simone Bergmann; Kristian Riesbeck; Anna M Blom
Journal:  J Biol Chem       Date:  2014-04-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.